ABO-mismatched platelet transfusions and clinical outcomes after cardiac surgery

Prophylactic half-dose platelet transfusion effect on thrombocytopenia, transfusion, and bleeding occurrence in patients with hematologic disease.

American journal of clinical pathology·2026

The case against infusing ABO incompatible antibody and antigen from all blood components.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026

The case for universal leukoreduction of blood transfusions.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2025

Creating a plasma coordination center to support COVID-19 outpatient trials across a national network of hospital blood banks.

Journal of clinical and translational science·2024

Patient blood management: Myths and facts about red blood cell transfusions.

Vox sanguinis·2023

Reduction of anti-A and anti-B isoagglutinin titers of group O whole blood units employing an ABO antibody immune adsorption column.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2023

Optimizing blood resource allocation in Oklahoma: A geospatial analysis of available supply and potential networks of distribution.

Transfusion·2026

First molecularly characterized Para-Bombay phenotype in Iraq: Clinical, serological and genetic insights with implications for transfusion safety.

Transfusion·2026

How do I manage catastrophic failure of liquid nitrogen storage for human cells, tissues, and cellular and tissue-based products?

Transfusion·2026

Molecular characterization of CD36 deficiency in blood donors of Middle Eastern and African origin reveals transcript-level defects beyond genomic variants.

Transfusion·2026

How do we remediate blood banking/transfusion medicine fellows?

Transfusion·2026

Same-day rescue plerixafor during leukapheresis is safe and effective in allogeneic donors suboptimally responding to granulocyte colony-stimulating factor mobilization.

Transfusion·2026

Related Experiment Videos

ABO-mismatched platelet transfusions and clinical outcomes after cardiac surgery

Related Concept Videos

Prophylactic half-dose platelet transfusion effect on thrombocytopenia, transfusion, and bleeding occurrence in patients with hematologic disease.

The case against infusing ABO incompatible antibody and antigen from all blood components.

The case for universal leukoreduction of blood transfusions.

Creating a plasma coordination center to support COVID-19 outpatient trials across a national network of hospital blood banks.

Patient blood management: Myths and facts about red blood cell transfusions.

Reduction of anti-A and anti-B isoagglutinin titers of group O whole blood units employing an ABO antibody immune adsorption column.

Optimizing blood resource allocation in Oklahoma: A geospatial analysis of available supply and potential networks of distribution.

First molecularly characterized Para-Bombay phenotype in Iraq: Clinical, serological and genetic insights with implications for transfusion safety.

How do I manage catastrophic failure of liquid nitrogen storage for human cells, tissues, and cellular and tissue-based products?

Molecular characterization of CD36 deficiency in blood donors of Middle Eastern and African origin reveals transcript-level defects beyond genomic variants.

How do we remediate blood banking/transfusion medicine fellows?

Same-day rescue plerixafor during leukapheresis is safe and effective in allogeneic donors suboptimally responding to granulocyte colony-stimulating factor mobilization.

Related Experiment Videos

ABO-mismatched platelet transfusions and clinical outcomes after cardiac surgery

Related Concept Videos

Related Articles